Patent No Sample Clauses

Patent No. Germany EP 88907510.7 Granted EP/0371998 Italy EP 88907510.7 Granted EP/0371998 Japan 506481/88 Granted 2991720 Luxembourg EP 88907510.7 Granted EP/0371998 Netherlands EP 88907510.7 Granted EP/0371998 Sweden EP 88907510.7 Granted EP/0371998 Switzerland/Liechtenstein EP 88907510.7 Granted EP/0371998 United Kingdom EP 88907510.7 Granted EP/0371998
Patent No. Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528
Patent No. United States 06/793,980 Australia 65981/86 Issued 606,320 Canada 521,909 Abandoned Denmark 3385/87 Pending Taiwan 75105650 Issued 51922 *United States U.S. National Phase of PCT/US86/02269
Patent No. United States 07/501,092 *United States 07/987,555 *United States 07/870,404 *United States 08/020,671 United States 08/235,225 5,618,920 United States 08/299,085 5,595,898 United States 08/472,691 6,204,023 United States 08/467,140 5,698,435 United States 08/450,731 5,693,493 United States 08/466,203 5,698,417 Title: Novel Plasmid Vector with Pectate Lyase Signal Sequence Inventors: Lei, Wilcox Based on U.S. Application No. 07/142,039 filed January 11, 1988 and PCT/US89/00077
Patent No. Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/ Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528 3) Based on U.S. Serial No. 07/501,092 filed March 29, 1990, which is a continuation-in-part of U.S. Serial No. 07/077,528 (Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use; Robinson, Liu, Horwitz, Wall, Better) and of U.S. Serial No. 07/142,039 (Novel Plasmid Vector with Pectate Lyase Signal Sequence; Lei, Wilcox).
Patent No. TITLE ---------- ---------- ----- 08211574 5612990 DIGITAL WIRELESS INTERFACE 09/902089 6775294 TIME SLOT ASSIGN FOR NX64 SWITCH SYSTEM 851422 6259703 TIME SLOT ASSIGN FOR NX64 SWITCH SYSTEM 08/191470 5544158 MULTIPLE ACCESS 5546025 5546025 LOW FREQUENCY DISCRIMINATOR CIRCUIT 08/235257 5532676 BATTERY SWITCH FOR RAM BACKUP 08225481 5,768,342 LOOP CURRENT DETECTOR 08/625302 5602843 INTEGRATED WIRED AND WIRELESS TELECOMMUNICATIONS SYSTEM 10/056404 n/a TRANSPORT PROTOCOL 09/826554 n/a HANDWARE AUTHENTICATION METHOD 10/101083 6785367 METHOD AND APPARATUS FOR EXTRACTING VOICED TELEPHONE NUMBERS AND EMAIL ADDRESSES FROM VOICE MAIL MESSAGES 894632 5323456 DIGITALLY CONTROLLED RINGER SIGNAL GENERATOR 07/708769 5164940 MODULAR COMMUNICATION SYSTEM WITH ALLOCATABLE BANDWIDTH SERIAL NO. PATENT NO. TITLE ---------- ---------- ----- 08065533 5649148 ST BUS DSP INTERFACE 09/563879 6754201 USING LINE APPEARANCE TO ALLOW MULTIPLE DEVICES TO APPEAR OVER A SINGLE LINE 09/779253 6456707 FEATURE PROVISIONING BY INJECTION 10/224063 6795533 INTERMEDIATE VOICE AND DTMF DETECTOR DEVICE FOR IMPROVED SPEECH RECOGNITION UTILIZATION AND PENETRATION 285659 4410766 POWER SAVING LINE CIRCUIT 08366668 5706341 ACTIVE DIGIT CANCELLING PARALLEL DIALER 08/843,250 5,940,500 SERIES EQUIPMENT WITH DC LINE HOLD TRANSFER 09/079280 6,185,297 LOW POWER DIALER 09/259985 6839411 QUICKPICK 09/259986 6745221 DYNAMIC RULES BASED RESOURCE ALLOCATION 09/258507 6,546,366 ON-DEMAND BUFFERING 09/259811 6,418,200 AUTOMATIC SYNCHRONIZATION OF ADDRESS DIRECTORIES FOR UNIFIED MESSAGING 09/258717 6795536 AUTOMATIC SELECTION OF USER PREFERENCES BASED ON CLI DATA 09/255,461 6,137,276 ONHOOK TELECOM POWER SUPPLY CURRENT REGULATOR MODE 09/260391 6,694,320 BRANDING DYNAMIC LINK LIBRARIES
Patent No. EXPIRES [***] [***] [***] [***] [***]
Patent No. United States 06/793,980 Australia 65981/86 Issued 606,320 Canada 521,909 Abandoned Denmark 3385/87 Pending Taiwan 75105650 Issued 51922 *United States 06/086,266 2) Based on PCT/US88/02514, which corresponds to U.S. Serial No. 07/077,528, which is a continuation-in-part of 06/086,266 (abandoned), which is a continuation-in-part of U.S. Serial No. 06/793,980 (abandoned).
Patent No. Patent Date Method and Composition for Ameliorating the Adverse Effects of Aging Greece Granted 91912579.9 0584068 10/6/99 Method and Composition for Ameliorating the Adverse Effects of Aging Ireland, Republic of Pending 1715/91 Method and Composition for Ameliorating the Adverse Effects of Aging Israel Granted 98204 98204 2/12/95 Method and Composition for Ameliorating the Adverse Effects of Aging Japan Granted 512066/91 Method and Composition for Ameliorating the Adverse Effects of Aging Japan (divisional) Pending 3103375 Method and Composition for Ameliorating the Adverse Effects of Aging Luxem- bourg Granted 91912579.9 0584068 10/6/99 Method and Composition for Ameliorating the Adverse Effects of Aging Korea, South Granted 703452/93 196660 2/22/99 Method and Composition for Ameliorating the Adverse Effects of Aging Malaysia Pending PI9100865 Method and Composition for Ameliorating the Adverse Effects of Aging Mexico Granted 25,886 178834 7/2/95 Method and Composition for Ameliorating the Adverse Effects of Aging Nether- lands Granted 91912579.9 0584068 10/6/99 Method and Composition for Ameliorating the Adverse Effects of Aging New Zealand Granted 238210 238210 10/1/93 Method and Composition for Ameliorating the Adverse Effects of Aging New Zealand Granted 247836 247836 8/8/97 Method and Composition for Ameliorating the Adverse Effects of Aging Norway Granted 934115 304814 2/22/99 Method and Composition for Ameliorating the Adverse Effects of Aging Philippines Pending 42893 Title Country Status Application No.
Patent No. [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] [...***...] ***CONFIDENTIAL TREATMENT REQUESTED